Patents Assigned to Presidio Medical, Inc.
  • Patent number: 11918803
    Abstract: Disclosed herein are systems and methods for nerve conduction block. The systems and methods can utilize at least one renewable electrode. The methods can include delivering a first direct current with a first polarity to an electrode proximate nervous tissue sufficient to block conduction in the nervous tissue. Delivering the first direct current can place the nervous tissue in a hypersuppressed state at least partially preventing conduction of the nervous tissue after cessation of delivering of the first direct current. The nervous tissue can be maintained in the hypersuppressed state for a desired period, such as at least about 1 minute.
    Type: Grant
    Filed: May 7, 2021
    Date of Patent: March 5, 2024
    Assignee: Presidio Medical, Inc.
    Inventors: Douglas Michael Ackermann, Kenneth Wu
  • Patent number: 11813459
    Abstract: Disclosed herein are systems and methods for nerve conduction block that can involve the delivery of relatively high amounts of charge safely to tissue. Such systems and methods can include control systems for safely monitoring a direct current electrode system, including delivering direct current via an electrode lead to a target tissue of a patient; measuring the driving voltage across the electrode; comparing the driving voltage across the electrode to predetermined threshold range values; measuring the body impedance; determining a voltage drop across the lead from the body impedance measurement; and adjusting the driving voltage to maintain the voltage drop across the lead within a predetermined voltage range.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: November 14, 2023
    Assignee: Presidio Medical, Inc.
    Inventors: Kenneth Wu, Douglas Michael Ackermann, Aaron Hardinger
  • Patent number: 11752329
    Abstract: Disclosed herein are systems and methods for nerve conduction block. The systems and methods can utilize at least one rechargeable electrode. The methods can include delivering a first direct current with a first polarity to an electrode proximate nervous tissue sufficient to at least partially block conduction in the nervous tissue.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: September 12, 2023
    Assignee: Presidio Medical, Inc.
    Inventors: Douglas Michael Ackermann, Kenneth Wu, Aaron Hardinger
  • Patent number: 11730964
    Abstract: Disclosed herein are systems and methods that can involve a neuromodulation device configured to perform in multiple electrical modulation modes with a single architecture.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: August 22, 2023
    Assignee: Presidio Medical, Inc.
    Inventors: Michael A. Faltys, Aaron Hardinger, James Harris, Douglas Michael Ackermann, Kenneth S. Wu
  • Patent number: 11577080
    Abstract: The invention refers to a device for inhibiting the neural activity of a carotid sinus nerve (CSN) or carotid body of a subject, the device comprising: one or more transducers configured to apply a signal to the CSN or associated carotid body of the subject, optionally at least two such transducers; and a controller coupled to the one or more transducers, the controller controlling the signal to be applied by the one or more transducers, such that the signal inhibits the neural activity of the CSN or carotid body to produce a physiological response in the subject, wherein the physiological response is one or more of the group consisting of: an increase in insulin sensitivity in the subject, an increase in glucose tolerance in the subject, a decrease in (fasting) plasma glucose concentration in the subject, a reduction in subcutaneous fat content in the subject, and a reduction in obesity in the subject.
    Type: Grant
    Filed: November 3, 2015
    Date of Patent: February 14, 2023
    Assignees: Presidio Medical, Inc., Faculdade De Ciências Médicas Da Universidade Nova De Lisboa
    Inventors: Silvia Margarida Vilares Santos Conde, Daniel John Chew, Hans Jakob Kristoffer Famm, Maria Pedro Sucena Guarino, Brad Holinski, Sonal Patel
  • Patent number: 11369793
    Abstract: Modulation, preferably inhibition, of neurosignaling of a cardiac-related sympathetic nerve in the extracardiac intrathoracic neural circuit is effective in stabilizing cardiac electrical and/or mechanical function, thereby providing ways of treating or preventing cardiac dysfunction such as arrhythmias.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: June 28, 2022
    Assignees: The Regents of the University of California, Presidio Medical, Inc.
    Inventors: Jeffrey Laurence Ardell, Kalyanam Shivkumar, Arun Sridhar
  • Patent number: 11027126
    Abstract: Disclosed herein are systems and methods for nerve conduction block. The systems and methods can utilize at least one renewable electrode. The methods can include delivering a first direct current with a first polarity to an electrode proximate nervous tissue sufficient to block conduction in the nervous tissue. Delivering the first direct current can place the nervous tissue in a hypersuppressed state at least partially preventing conduction of the nervous tissue after cessation of delivering of the first direct current. The nervous tissue can be maintained in the hypersuppressed state for a desired period, such as at least about 1 minute.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: June 8, 2021
    Assignee: Presidio Medical, Inc.
    Inventors: Douglas Michael Ackermann, Kenneth Wu
  • Patent number: 10272240
    Abstract: Disclosed herein are systems and methods for nerve conduction block. The systems and methods can utilize at least one renewable electrode. The methods can include delivering a first direct current with a first polarity to an electrode proximate nervous tissue sufficient to block conduction in the nervous tissue. Delivering the first direct current can place the nervous tissue in a hypersuppressed state at least partially preventing conduction of the nervous tissue after cessation of delivering of the first direct current. The nervous tissue can be maintained in the hypersuppressed state for a desired period, such as at least about 1 minute.
    Type: Grant
    Filed: April 2, 2018
    Date of Patent: April 30, 2019
    Assignee: Presidio Medical, Inc.
    Inventors: Douglas Michael Ackermann, Kenneth Wu